|
MED14 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.693970E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.079600E-01 |
| Normal-vs-Stage2 |
1.118570E-01 |
| Normal-vs-Stage3 |
1.752640E-01 |
| Normal-vs-Stage4 |
3.155600E-01 |
| Stage1-vs-Stage2 |
2.201000E-01 |
| Stage1-vs-Stage3 |
3.133400E-01 |
| Stage1-vs-Stage4 |
5.396200E-01 |
| Stage2-vs-Stage3 |
9.121000E-01 |
| Stage2-vs-Stage4 |
6.557800E-01 |
| Stage3-vs-Stage4 |
7.376600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.524000E-01 |
| Normal-vs-AfricanAmerican |
1.780700E-03 |
| Normal-vs-Asian |
1.332200E-01 |
| Caucasian-vs-AfricanAmerican |
1.118120E-02 |
| Caucasian-vs-Asian |
2.708100E-02 |
| AfricanAmerican-vs-Asian |
6.811200E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.014020E-01 |
| Normal-vs-Female |
5.803800E-01 |
| Male-vs-Female |
2.816000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.414440E-01 |
| Normal-vs-Age(41-60Yrs) |
5.092600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.034600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.704200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.441000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.035200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.146800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.682200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.191600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.152760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.732800E-01 |
| Normal-vs-Grade 2 |
5.454600E-01 |
| Normal-vs-Grade 3 |
2.337200E-01 |
| Normal-vs-Grade 4 |
1.925960E-02 |
| Grade 1-vs-Grade 2 |
5.653400E-01 |
| Grade 1-vs-Grade 3 |
2.704800E-01 |
| Grade 1-vs-Grade 4 |
1.347980E-01 |
| Grade 2-vs-Grade 3 |
4.464600E-01 |
| Grade 2-vs-Grade 4 |
3.434300E-02 |
| Grade 3-vs-Grade 4 |
2.093200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.357000E-01 |
| Normal-vs-ccB subtype |
7.395600E-01 |
| ccA subtype-vs-ccB subtype |
9.406400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.992400E-01 |
| Normal-vs-N1 |
4.254200E-01 |
| N0-vs-N1 |
5.948800E-01 |
|
|
